News & Blog

Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy

September/October 2025 – Advocacy Newsletter

Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia

Webinar Recording: Solid Biosciences September 2025 Update

Siblings Jake and Claire Juip face Friedreich’s ataxia together

Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights

Webinar Recording: Larimar June 2025 Update

Press Release & Community Statement: PTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA

August 2025 – Advocacy Newsletter

Take Action to Raise Awareness for FA—Submit a Proclamation Request!

Job Posting: Research Portfolio Manager

FA Community Conversations FA Drug Development Pipeline Webinar: Recording Available on YouTube